|
| | Publication Year | Title | Author(s) |
| 1 | 1-Nov-2004 | Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. | Jerums, George ; Allen, Terri J; Campbell, D J; Cooper, Mark E; Gilbert, Richard E; Hammond, J J; O'Brien, R C; Raffaele, J; Tsalamandris, Con |
| 2 | 1-Jan-2004 | New insights into the significance of microalbuminuria. | MacIsaac, Richard J; Jerums, George ; Cooper, Mark E |
| 3 | 1-Nov-2003 | Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. | Jerums, George ; Panagiotopoulos, Sianna ; Forbes, Josephine M; Osicka, Tanya M; Cooper, Mark E |
| 4 | 6-May-2003 | The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications. | McRobert, E Anne; Gallicchio, Marisa; Jerums, George ; Cooper, Mark E; Bach, Leon A |
| 5 | 1-Nov-2002 | Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. | Forbes, Josephine M; Cooper, Mark E; Thallas, Vicki; Burns, Wendy C; Thomas, Merlin C; Brammar, Gail C; Lee, Fook-Thean; Grant, Sharon L; Burrell, Louise M ; Burrell, Louise A; Jerums, George ; Osicka, Tanya M |
| 6 | 1-Jun-2002 | Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. | Houlihan, Christine A ; Akdeniz, Aysel; Tsalamandris, Con; Cooper, Mark E; Jerums, George ; Gilbert, Richard E |
| 7 | 1-May-2002 | Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. | Forbes, Josephine M; Bonnet, Fabrice; Russo, Leileata M; Burns, Wendy C; Cao, Zemin; Candido, Riccardo; Kawachi, Hiroshi; Allen, Terri J; Cooper, Mark E; Jerums, George ; Osicka, Tanya M |
| 8 | 1-Apr-2002 | A low-sodium diet potentiates the effects of losartan in type 2 diabetes. | Houlihan, Christine A ; Allen, Terri J; Baxter, Amynta L; Panangiotopoulos, Sianna; Casley, David J; Cooper, Mark E; Jerums, George |
| 9 | 1-Dec-2001 | Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). | Oldfield, M D; Bach, Leon A; Forbes, J M; Nikolic-Paterson, D; McRobert, A; Thallas, Vicki; Atkins, R C; Osicka, Tanya M; Jerums, George ; Cooper, Mark E |
| 10 | 1-May-2001 | Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. | Jerums, George ; Allen, Terri J; Campbell, D J; Cooper, Mark E; Gilbert, Richard E; Hammond, J J; Raffaele, J; Tsalamandris, Con |
| 11 | 1-Jan-2001 | Renoprotective effects of a novel inhibitor of advanced glycation. | Forbes, J M; Soulis, T; Thallas, Vicki; Panagiotopoulos, Sianna ; Long, D M; Vasan, S; Wagle, D; Jerums, George ; Cooper, Mark E |
| 12 | 1-Nov-2000 | Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. | Gilbert, Richard E; Kelly, D J; Cox, Allison J; Wilkinson-Berka, J L; Rumble, J R; Osicka, Tanya M; Panagiotopoulos, Sianna ; Lee, V ; Hendrich, E C; Jerums, George ; Cooper, Mark E |
Loading...
2
0
20
0
false